MARK SHEPTOFF FINANCIAL PLANNING, LLC - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 158 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
MARK SHEPTOFF FINANCIAL PLANNING, LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$0–100.0%0.00%–
Q4 2019$0–100.0%0.00%–
Q3 2019$0–100.0%0.00%–
Q2 2019$0–100.0%0.00%–
Q1 2019$0–100.0%0.00%–
Q4 2018$0–100.0%0.00%–
Q3 2018$0–100.0%0.00%–
Q2 2018$0–100.0%0.00%–
Q1 2018$0–100.0%0.00%–
Q4 2017$0–100.0%0.00%–
Q3 2017$0–100.0%0.00%–
Q2 2017$0–10
-9.1%
0.00%–
Q1 2017$0–11
+10.0%
0.00%–
Q4 2016$0–100.0%0.00%–
Q3 2016$0–100.0%0.00%–
Q2 2016$0–100.0%0.00%–
Q1 2016$0–100.0%0.00%–
Q4 2015$0–100.0%0.00%–
Q3 2015$0–100.0%0.00%–
Q2 2015$0–100.0%0.00%–
Q1 2015$0–100.0%0.00%–
Q4 2014$0–100.0%0.00%–
Q3 2014$0–100.0%0.00%–
Q2 2014$0–100.0%0.00%–
Q1 2014$0–10–0.00%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q2 2018.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders